The Resource Incentives for global public health : patent law and access to essential medicines, edited by Thomas Pogge, Matthew Rimmer, and Kim Rubenstein, (electronic resource)
Incentives for global public health : patent law and access to essential medicines, edited by Thomas Pogge, Matthew Rimmer, and Kim Rubenstein, (electronic resource)
Resource Information
The item Incentives for global public health : patent law and access to essential medicines, edited by Thomas Pogge, Matthew Rimmer, and Kim Rubenstein, (electronic resource) represents a specific, individual, material embodiment of a distinct intellectual or artistic creation found in European University Institute.This item is available to borrow from 1 library branch.
Resource Information
The item Incentives for global public health : patent law and access to essential medicines, edited by Thomas Pogge, Matthew Rimmer, and Kim Rubenstein, (electronic resource) represents a specific, individual, material embodiment of a distinct intellectual or artistic creation found in European University Institute.
This item is available to borrow from 1 library branch.
- Summary
- This portrait of the global debate over patent law and access to essential medicines focuses on public health concerns about HIV/AIDS, malaria, tuberculosis, the SARS virus, influenza, and diseases of poverty. The essays explore the diplomatic negotiations and disputes in key international fora, such as the World Trade Organization, the World Health Organization and the World Intellectual Property Organization. Drawing upon international trade law, innovation policy, intellectual property law, health law, human rights and philosophy, the authors seek to canvass policy solutions which encourage and reward worthwhile pharmaceutical innovation while ensuring affordable access to advanced medicines. A number of creative policy options are critically assessed, including the development of a Health Impact Fund, prizes for medical innovation, the use of patent pools, open-source drug development and forms of 'creative capitalism'.--
- Language
- eng
- Extent
- 1 online resource (xxi, 512 pages)
- Contents
-
- Introduction: access to essential medicines: public health and international law / Thomas Pogge, Matthew Rimmer and Kim Rubenstein
- TRIPS and essential medicines: must one size fit all? Making the WTO responsive to the global health crisis / Rochelle C. Dreyfuss
- The TRIPS waiver as a recognition of public health concerns in the WTO / Andrew D. Mitchell and Tania Voon
- Public law challenges to the regulation of pharmaceutical patents in the US bilateral free trade agreements / Hitoshi Nasu
- Global health and development: patents and public interest / Elizabeth Siew Kuan Ng
- The Health Impact Fund: better pharmaceutical innovations at much lower price / Thomas Pogge
- The Health Impact Fund: a critique / Kathleen Liddell
- A prize system as a partial solution to the health crisis in the developing world / William W. Fisher and Talha Syed
- Innovation and insufficient evidence: the case for a WTO-WHO agreement on health technology safety and cost-effectiveness evaluation / Thomas Faunce
- Opening the dam: patent pools, innovation, and access to essential medicines / Dianne Nicol and Jane Nielsen
- Open source drug discovery: a revolutionary paradigm or a Utopian model? Krishna Ravi Srinivas
- Accessing and benefit sharing avian influenza viruses through the World Health Organisation: a CBD and TRIPS compromise thanks to Indonesia's sovereignty claim? / Charles Lawson and Barbara Ann Hocking
- The Lazarus effect: the (RED) campaign and creative capitalism / Matthew Rimmer
- Beyond TRIPS: the role of non-state actors and access to essential medicines / Noah Benjamin Novogrodsky
- Securing health through rights / Katharine G. Young
- The role of national laws in reconciling constitutional right to health with TRIPS obligations: an examination of the Glivec patent case in India / Rajshree Chandra
- Tipping point: Thai compulsory licenses redefine essential medicines debate / Jonathan Burton-MacLeod
- Isbn
- 9781107693456
- Label
- Incentives for global public health : patent law and access to essential medicines
- Title
- Incentives for global public health
- Title remainder
- patent law and access to essential medicines
- Statement of responsibility
- edited by Thomas Pogge, Matthew Rimmer, and Kim Rubenstein
- Language
- eng
- Summary
- This portrait of the global debate over patent law and access to essential medicines focuses on public health concerns about HIV/AIDS, malaria, tuberculosis, the SARS virus, influenza, and diseases of poverty. The essays explore the diplomatic negotiations and disputes in key international fora, such as the World Trade Organization, the World Health Organization and the World Intellectual Property Organization. Drawing upon international trade law, innovation policy, intellectual property law, health law, human rights and philosophy, the authors seek to canvass policy solutions which encourage and reward worthwhile pharmaceutical innovation while ensuring affordable access to advanced medicines. A number of creative policy options are critically assessed, including the development of a Health Impact Fund, prizes for medical innovation, the use of patent pools, open-source drug development and forms of 'creative capitalism'.--
- Assigning source
- Provided by publisher
- Cataloging source
- UkCbUP
- Index
- index present
- Literary form
- non fiction
- Nature of contents
- dictionaries
- http://library.link/vocab/relatedWorkOrContributorDate
- 1953-
- http://library.link/vocab/relatedWorkOrContributorName
-
- Pogge, Thomas
- Rimmer, Matthew
- Rubenstein, Kim
- Series statement
-
- Connecting international law with public law
- Cambridge Social Sciences eBooks
- http://library.link/vocab/subjectName
-
- Pharmaceutical policy
- Patent laws and legislation
- Drugs
- Patents (International law)
- Label
- Incentives for global public health : patent law and access to essential medicines, edited by Thomas Pogge, Matthew Rimmer, and Kim Rubenstein, (electronic resource)
- Carrier category
- online resource
- Carrier category code
-
- cr
- Carrier MARC source
- rdacarrier
- Content category
- text
- Content type code
-
- txt
- Content type MARC source
- rdacontent
- Contents
- Introduction: access to essential medicines: public health and international law / Thomas Pogge, Matthew Rimmer and Kim Rubenstein -- TRIPS and essential medicines: must one size fit all? Making the WTO responsive to the global health crisis / Rochelle C. Dreyfuss -- The TRIPS waiver as a recognition of public health concerns in the WTO / Andrew D. Mitchell and Tania Voon -- Public law challenges to the regulation of pharmaceutical patents in the US bilateral free trade agreements / Hitoshi Nasu -- Global health and development: patents and public interest / Elizabeth Siew Kuan Ng -- The Health Impact Fund: better pharmaceutical innovations at much lower price / Thomas Pogge -- The Health Impact Fund: a critique / Kathleen Liddell -- A prize system as a partial solution to the health crisis in the developing world / William W. Fisher and Talha Syed -- Innovation and insufficient evidence: the case for a WTO-WHO agreement on health technology safety and cost-effectiveness evaluation / Thomas Faunce -- Opening the dam: patent pools, innovation, and access to essential medicines / Dianne Nicol and Jane Nielsen -- Open source drug discovery: a revolutionary paradigm or a Utopian model? Krishna Ravi Srinivas -- Accessing and benefit sharing avian influenza viruses through the World Health Organisation: a CBD and TRIPS compromise thanks to Indonesia's sovereignty claim? / Charles Lawson and Barbara Ann Hocking -- The Lazarus effect: the (RED) campaign and creative capitalism / Matthew Rimmer -- Beyond TRIPS: the role of non-state actors and access to essential medicines / Noah Benjamin Novogrodsky -- Securing health through rights / Katharine G. Young -- The role of national laws in reconciling constitutional right to health with TRIPS obligations: an examination of the Glivec patent case in India / Rajshree Chandra -- Tipping point: Thai compulsory licenses redefine essential medicines debate / Jonathan Burton-MacLeod
- Control code
- CR9780511750786
- Dimensions
- unknown
- Extent
- 1 online resource (xxi, 512 pages)
- Form of item
- online
- Governing access note
- Use of this electronic resource may be governed by a license agreement which restricts use to the European University Institute community. Each user is responsible for limiting use to individual, non-commercial purposes, without systematically downloading, distributing, or retaining substantial portions of information, provided that all copyright and other proprietary notices contained on the materials are retained. The use of software, including scripts, agents, or robots, is generally prohibited and may result in the loss of access to these resources for the entire European University Institute community
- Isbn
- 9781107693456
- Media category
- computer
- Media MARC source
- rdamedia
- Media type code
-
- c
- Other physical details
- digital, PDF file(s).
- Specific material designation
- remote
- System control number
- (OCoLC)659564730
- Label
- Incentives for global public health : patent law and access to essential medicines, edited by Thomas Pogge, Matthew Rimmer, and Kim Rubenstein, (electronic resource)
- Carrier category
- online resource
- Carrier category code
-
- cr
- Carrier MARC source
- rdacarrier
- Content category
- text
- Content type code
-
- txt
- Content type MARC source
- rdacontent
- Contents
- Introduction: access to essential medicines: public health and international law / Thomas Pogge, Matthew Rimmer and Kim Rubenstein -- TRIPS and essential medicines: must one size fit all? Making the WTO responsive to the global health crisis / Rochelle C. Dreyfuss -- The TRIPS waiver as a recognition of public health concerns in the WTO / Andrew D. Mitchell and Tania Voon -- Public law challenges to the regulation of pharmaceutical patents in the US bilateral free trade agreements / Hitoshi Nasu -- Global health and development: patents and public interest / Elizabeth Siew Kuan Ng -- The Health Impact Fund: better pharmaceutical innovations at much lower price / Thomas Pogge -- The Health Impact Fund: a critique / Kathleen Liddell -- A prize system as a partial solution to the health crisis in the developing world / William W. Fisher and Talha Syed -- Innovation and insufficient evidence: the case for a WTO-WHO agreement on health technology safety and cost-effectiveness evaluation / Thomas Faunce -- Opening the dam: patent pools, innovation, and access to essential medicines / Dianne Nicol and Jane Nielsen -- Open source drug discovery: a revolutionary paradigm or a Utopian model? Krishna Ravi Srinivas -- Accessing and benefit sharing avian influenza viruses through the World Health Organisation: a CBD and TRIPS compromise thanks to Indonesia's sovereignty claim? / Charles Lawson and Barbara Ann Hocking -- The Lazarus effect: the (RED) campaign and creative capitalism / Matthew Rimmer -- Beyond TRIPS: the role of non-state actors and access to essential medicines / Noah Benjamin Novogrodsky -- Securing health through rights / Katharine G. Young -- The role of national laws in reconciling constitutional right to health with TRIPS obligations: an examination of the Glivec patent case in India / Rajshree Chandra -- Tipping point: Thai compulsory licenses redefine essential medicines debate / Jonathan Burton-MacLeod
- Control code
- CR9780511750786
- Dimensions
- unknown
- Extent
- 1 online resource (xxi, 512 pages)
- Form of item
- online
- Governing access note
- Use of this electronic resource may be governed by a license agreement which restricts use to the European University Institute community. Each user is responsible for limiting use to individual, non-commercial purposes, without systematically downloading, distributing, or retaining substantial portions of information, provided that all copyright and other proprietary notices contained on the materials are retained. The use of software, including scripts, agents, or robots, is generally prohibited and may result in the loss of access to these resources for the entire European University Institute community
- Isbn
- 9781107693456
- Media category
- computer
- Media MARC source
- rdamedia
- Media type code
-
- c
- Other physical details
- digital, PDF file(s).
- Specific material designation
- remote
- System control number
- (OCoLC)659564730
Library Links
Embed
Settings
Select options that apply then copy and paste the RDF/HTML data fragment to include in your application
Embed this data in a secure (HTTPS) page:
Layout options:
Include data citation:
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.library.eui.eu/portal/Incentives-for-global-public-health--patent-law/rjxg2GYrumM/" typeof="Book http://bibfra.me/vocab/lite/Item"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.library.eui.eu/portal/Incentives-for-global-public-health--patent-law/rjxg2GYrumM/">Incentives for global public health : patent law and access to essential medicines, edited by Thomas Pogge, Matthew Rimmer, and Kim Rubenstein, (electronic resource)</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.library.eui.eu/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.library.eui.eu/">European University Institute</a></span></span></span></span></div>
Note: Adjust the width and height settings defined in the RDF/HTML code fragment to best match your requirements
Preview
Cite Data - Experimental
Data Citation of the Item Incentives for global public health : patent law and access to essential medicines, edited by Thomas Pogge, Matthew Rimmer, and Kim Rubenstein, (electronic resource)
Copy and paste the following RDF/HTML data fragment to cite this resource
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.library.eui.eu/portal/Incentives-for-global-public-health--patent-law/rjxg2GYrumM/" typeof="Book http://bibfra.me/vocab/lite/Item"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.library.eui.eu/portal/Incentives-for-global-public-health--patent-law/rjxg2GYrumM/">Incentives for global public health : patent law and access to essential medicines, edited by Thomas Pogge, Matthew Rimmer, and Kim Rubenstein, (electronic resource)</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.library.eui.eu/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.library.eui.eu/">European University Institute</a></span></span></span></span></div>
